# ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

> **NCT00466063** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 108 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Deferasirox

## Key facts

- **NCT ID:** NCT00466063
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2015-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466063, "ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00466063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*